Experience of mezlocillin in immunocompromised patients.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance; D008802:Mezlocillin; D009369:Neoplasms / Q000276:immunology / Q000382:microbiology; D010406:Penicillins / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy; D012853:Sisomicin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010406:Penicillins; D008802:Mezlocillin; D012853:Sisomicin